In a promising start to the week, the S&P 500 and Nasdaq are projected to open higher today, aiming to build on the record-high closes from the previous day. The upward momentum follows a reported 0.6% increase in retail sales for August, a figure that significantly surpasses analysts’ expectations of a 0.2% rise. This retail sales data becomes particularly crucial as the Federal Reserve prepares for its upcoming interest rate decision scheduled for tomorrow afternoon.
Amazon is in the spotlight with an upgraded price target from Truist, raised to $270 from the previous $250. Analyzing card data through September 6, Truist noted that Amazon’s North American revenue is tracking approximately $1 billion above consensus estimates. Additionally, the retailer has announced a two-day sales event in October to herald the start of the holiday shopping season.
Oracle shares are experiencing a rise in premarket trading following a CBS News report suggesting the company is among several firms that may oversee TikTok’s U.S. operations. This move would potentially allow TikTok to bypass a ban in the country. Analyst Jim Cramer highlighted the application’s ad-targeting capabilities, making it a valuable asset for the firms involved.
Similarly, Mizuho has raised its price target for Micron to $182, up from $155, ahead of the company’s earnings report next Tuesday. Expectations for high bandwidth memory (HBM) estimates are driving this bullish outlook, particularly with the ramp-up of Nvidia’s new Blackwell Ultra chip. Micron shares have surged approximately 30% over the past month.
In banking, Wells Fargo analyst Mike Mayo has reaffirmed his “Goliath is Winning” thesis, suggesting that the largest banks are faring best under current market conditions. He has increased the price targets for several financial giants, including Goldman Sachs, Bank of America, Citigroup, and JPMorgan, while also raising the target for Morgan Stanley despite maintaining a hold rating.
Microsoft announced an increase of 10% to its quarterly dividend, raising the annual yield to about 0.7% from 0.6%. This adjustment aligns with the company’s five-year average and comes alongside a substantial $55 billion left in its current buyback authorization, strengthening its overall capital return approach.
In retail, Citi has raised Nike’s price target to $74 from $68 while maintaining a neutral rating. The analyst anticipates better-than-expected earnings when the company reports on September 30, largely due to improved sales and diminished operational costs. Inventory levels are expected to be streamlined by the end of the fiscal second quarter, leading to a more favorable outlook for the brand.
Union Pacific received a second consecutive upgrade, with Loop Capital raising its forecast from sell to hold, noting that valuations are nearing the lower end of their five-year range. The company, along with Norfolk Southern, is currently seeking regulatory approval for its megamerger.
Novo Nordisk has been upgraded to buy at Rothschild & Co., which cites an attractive valuation for the company. The announcement follows positive late-stage study results for its once-weekly weight loss drug, Cagrilintide, which showed an average weight loss of 11.8%. This drug works by targeting a different hormone than existing GLP-1 offerings. Conversely, JPMorgan has lowered its price target for Eli Lilly from $1,100 to $1,050 while maintaining an overweight buy rating.
Finally, Bank of America elevated industrial real estate firm Prologis from hold to buy while raising its price target to $130 from $118. The analysis indicates that improvements in corporate decision-making are likely enhancing the conversion rate for new lease proposals.
Subscribers to the CNBC Investing Club with Jim Cramer are reminded that they will receive trade alerts prior to any transaction in the charitable trust’s portfolio, with specific waiting periods before executing trades.
